Training and Resources
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]
KEYTRUDA® (pembrolizumab) in metastatic colorectal cancer (CRC)
KEYTRUDA® (pembrolizumab) KEYNOTE-177 clinical data presentation
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
Review of KEYNOTE-177 study and outcomes
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
Testing for MSI/MMR status at diagnosis; a key for the 1L treatment of eligible patients with advanced CRC
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
KEYTRUDA® monotherapy
A guide to KEYTRUDA® (pembrolizumab) and how to manage immune-mediated adverse events
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
KEYTRUDA mode of action
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
Patient education and support materials
More information about KEYTRUDA® (pembrolizumab) in metastatic CRC
Supporting documentation
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website
